These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29576815)

  • 21. Determinants of discontinuation of initial highly active antiretroviral therapy regimens in a US HIV-infected patient cohort.
    Yuan Y; L'italien G; Mukherjee J; Iloeje UH
    HIV Med; 2006 Apr; 7(3):156-62. PubMed ID: 16494629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of highly active antiretroviral therapy in HIV-1 infected children.
    van Rossum AM; Fraaij PL; de Groot R
    Lancet Infect Dis; 2002 Feb; 2(2):93-102. PubMed ID: 11901656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of pill burden on discontinuation of the initial HAART regimen in minority female patients prescribed 1 pill/day versus any other pill burden.
    Hill S; Kavookjian J; Qian J; Chung A; Vandewaa J
    AIDS Care; 2014; 26(5):595-601. PubMed ID: 24111921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of adherence to highly active antiretroviral therapy (HAART) in Chinese HIV/AIDS patients.
    Fong OW; Ho CF; Fung LY; Lee FK; Tse WH; Yuen CY; Sin KP; Wong KH
    HIV Med; 2003 Apr; 4(2):133-8. PubMed ID: 12702134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens.
    Horberg M; Silverberg M; Hurley L; Delorenze G; Quesenberry C
    AIDS Patient Care STDS; 2008 Apr; 22(4):301-12. PubMed ID: 18338961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of gender on response to highly active antiretroviral therapy in HIV-1 infected patients: a nationwide population-based cohort study.
    Thorsteinsson K; Ladelund S; Jensen-Fangel S; Johansen IS; Katzenstein TL; Pedersen G; Storgaard M; Obel N; Lebech AM
    BMC Infect Dis; 2012 Nov; 12():293. PubMed ID: 23140254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of modifying or discontinuing first HAART regimen and its determinants in a cohort of HIV-infected patients from Rio de Janeiro, Brazil.
    Cardoso SW; Grinsztejn B; Velasque L; Veloso VG; Luz PM; Friedman RK; Morgado M; Ribeiro SR; Moreira RI; Keruly J; Moore RD
    AIDS Res Hum Retroviruses; 2010 Aug; 26(8):865-74. PubMed ID: 20672997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence.
    Stone VE; Jordan J; Tolson J; Miller R; Pilon T
    J Acquir Immune Defic Syndr; 2004 Jul; 36(3):808-16. PubMed ID: 15213564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of highly active antiretroviral therapy on liver function in human immunodeficiency virus-infected pediatric patients with or without hepatitis virus co-infection.
    Wu L; Jin C; Bai S; Davies H; Rao H; Liang Y; Wu N
    J Res Med Sci; 2015 Feb; 20(2):127-32. PubMed ID: 25983763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy.
    Golub ET; Benning L; Sharma A; Gandhi M; Cohen MH; Young M; Gange SJ
    Clin Infect Dis; 2008 Jan; 46(2):305-12. PubMed ID: 18171267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial experience of a public sector antiretroviral treatment programme for HIV-infected children and their infected parents.
    Eley B; Nuttall J; Davies MA; Smith L; Cowburn C; Buys H; Hussey G
    S Afr Med J; 2004 Aug; 94(8):643-6. PubMed ID: 15352588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS.
    Haddad M; Inch C; Glazier RH; Wilkins AL; Urbshott G; Bayoumi A; Rourke S
    Cochrane Database Syst Rev; 2000; (3):CD001442. PubMed ID: 10908497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of anaemia in HIV-infected children at the University of Abuja Teaching Hospital, Gwagwalada.
    Okechukwu AA; Gambo D; Okechukwu IO
    Niger J Med; 2010; 19(1):50-7. PubMed ID: 20232757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Causes for antiretroviral regimen change among HIV/AIDS patients in Addis Ababa, Ethiopia.
    Jima YT; Angamo MT; Wabe NT
    Tanzan J Health Res; 2013 Jan; 15(1):11-8. PubMed ID: 26591668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors affecting first month adherence due to antiretroviral therapy among HIV-positive adults at Felege Hiwot Teaching and Specialized Hospital, north-western Ethiopia; a prospective study.
    Tegegne AS; Ndlovu P; Zewotir T
    BMC Infect Dis; 2018 Feb; 18(1):83. PubMed ID: 29458343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disease progression in HIV-1 infected children and adolescents--results of a German-Austrian cohort study.
    Funk MB; Buchholz B; Notheis G; Neubert J; Feiterna-Sperling C; Ganschow R; Simon T; Hornemann F; Peters AM; Rütschle H; Horneff G; Lechner E; Hanschmann KM; Wintergerst U;
    Eur J Med Res; 2008 Aug; 13(8):371-8. PubMed ID: 18952519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.
    Nieuwkerk PT; Sprangers MA; Burger DM; Hoetelmans RM; Hugen PW; Danner SA; van Der Ende ME; Schneider MM; Schrey G; Meenhorst PL; Sprenger HG; Kauffmann RH; Jambroes M; Chesney MA; de Wolf F; Lange JM;
    Arch Intern Med; 2001 Sep; 161(16):1962-8. PubMed ID: 11525698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly active antiretroviral therapy discontinuation time is associated with therapeutic failure among human immunodeficiency virus (HIV)-infected immigrant adults: A cohort study from a Peruvian referral hospital during the Venezuelan exodus.
    Rebolledo-Ponietsky K; Al-Kassab-Córdova A; Lucchetti-Rodríguez A; Cabieses B; Rodriguez-Morales AJ; Mezones-Holguín E
    Trop Med Int Health; 2023 Aug; 28(8):641-652. PubMed ID: 37414409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.